Search Results - "Sancho, Aranzazu"
-
1
Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern
Published in Journal of medical virology (01-03-2023)“…The humoral immune response against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants of concern elicited by vaccination was evaluated in…”
Get full text
Journal Article -
2
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Published in Orphanet journal of rare diseases (15-11-2018)“…To assess uncertainty in regulatory decision-making for orphan medicinal products (OMP), a summary of the current basis for approval is required; a systematic…”
Get full text
Journal Article -
3
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Published in Current controlled trials in cardiovascular medicine (27-06-2022)“…Pneumonia is the primary cause of death among HIV-infected children in Africa, with mortality rates as high as 35-40% in infants hospitalized with severe…”
Get full text
Journal Article -
4
EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma
Published in The oncologist (Dayton, Ohio) (01-12-2020)“…The use of daratumumab in combination with established regimens for the treatment of newly diagnosed multiple myeloma has recently been authorized by the…”
Get full text
Journal Article -
5
A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study)
Published in Orphanet journal of rare diseases (20-08-2018)“…Minocycline is an old tetracycline antibiotic that has shown antiinflammatory and antiapoptotic properties in different neurological disease mouse models…”
Get full text
Journal Article -
6
Applicability and added value of novel methods to improve drug development in rare diseases
Published in Orphanet journal of rare diseases (12-11-2018)“…The ASTERIX project developed a number of novel methods suited to study small populations. The objective of this exercise was to evaluate the applicability and…”
Get full text
Journal Article -
7
Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm
Published in JMIR research protocols (01-09-2022)“…Aspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety…”
Get full text
Journal Article -
8
CLINICAL RESEARCH AND DRUG REGULATION IN THE CHALLENGING TIMES OF INDIVIDUALIZED THERAPIES: A PIVOTAL ROLE OF CLINICAL PHARMACOLOGY
Published in Pharmacological research (01-01-2024)“…Since the 1980s, medical specialists in Clinical Pharmacology have been playing a crucial role in the development of drug regulation in Spain. In this article…”
Get full text
Journal Article -
9
Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)
Published in Epilepsy & behavior (01-08-2023)“…•Drug-resistant epilepsy (DRE) is considered a severe condition.•DRE is associated with important burden for patients and the healthcare system.•Cenobamate…”
Get full text
Journal Article -
10
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial
Published in Current controlled trials in cardiovascular medicine (16-09-2020)“…In some patients, acute, life-threatening respiratory injury produced by viruses such as SARS-CoV and other viral pneumonia are associated with an…”
Get full text
Journal Article -
11
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
Published in Current controlled trials in cardiovascular medicine (20-01-2021)“…COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. At the time this clinical trial…”
Get full text
Journal Article -
12
Bronchopulmonary penetration of isavuconazole in lung transplant recipients
Published in Antimicrobial agents and chemotherapy (18-10-2023)“…Isavuconazole’s (ISA) pharmacokinetics was studied among lung transplant recipients to evaluate its bronchopulmonary penetration. This study included 13…”
Get full text
Journal Article -
13
The Right Time for Steroids in COVID-19
Published in Clinical infectious diseases (26-04-2021)Get full text
Journal Article -
14
Clinical features and predictors of delayed neurological syndrome in carbon monoxide poisoning: the AMICO study
Published in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias (01-04-2024)“…To identify predictors for developing delayed neurological syndrome (DNS) after an initial episode of carbon monoxide (CO) poisoning in the interest of…”
Get more information
Journal Article -
15
-
16
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis
Published in JAMA : the journal of the American Medical Association (10-08-2021)“…IMPORTANCE: Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and…”
Get full text
Journal Article -
17
Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics
Published in European journal of clinical pharmacology (01-06-2024)“…Purpose In order to explore clinical pharmacology and therapeutics (CPT) teaching and practices across continental Europe, the European Association of Clinical…”
Get full text
Journal Article -
18
Red blood cell distribution width as a marker of hyperinflammation and mortality in COVID-19
Published in Annals of palliative medicine (01-08-2022)Get full text
Journal Article -
19
-
20
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality
Published in Antimicrobial agents and chemotherapy (20-08-2020)“…Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia is lacking. We aim to determine the impact of steroid use for COVID-19…”
Get full text
Journal Article